AKT1 and malignant colon neoplasm: In colon cancer cells, SHP2 activates AKT to promote oxaliplatin resistance [37].Our study found that TKT activated the phosphorylated expression of AKT and oxaliplatin resistance process of GC cells, which are consistent with the above reports [33–37].